Summit Therapeutics Inc. (NASDAQ: SMMT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SUMMIT THERAPEUTICS INC.

Summit Therapeutics Inc. (NASDAQ: SMMT)
Listen to this Section


$15.07
N/A ( 0% ) 13.3K

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Market Data


Open $15.07
Previous Close $15.07
Volume 13.3K
Market Cap $11.70B
Day Range $14.75 - $14.93
52 Week Range $13.83 - $30.98
Shares Outstanding 776.16M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2015
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 16,248,427.00

Date Type Amount Purchased Purchaser
2025-10-23 Buy 13980789.00 DUGGAN ROBERT W
2025-10-23 Buy 266808.00 Zanganeh Mahkam
2025-10-23 Buy 533617.00 Xia Yu
2025-10-23 Buy 266808.00 Zanganeh Mahkam
2025-10-23 Buy 533617.00 Xia Yu
2025-09-11 Buy 333394.00 DUGGAN ROBERT W
2025-09-11 Buy 333394.00 Zanganeh Mahkam

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025
8-k 8K-related 42 Sep 08, 2025
8-k 8K-related 18 Aug 11, 2025
8-k 8K-related 27 Aug 11, 2025
10-q Quarterly Reports 170 Aug 11, 2025
8-k 8K-related 13 Jun 20, 2025
8-k 8K-related 13 Jun 17, 2025
4 Insider transactions 1 Jun 02, 2025
4 Insider transactions 1 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy